 Amneet Sandhu
Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 18 | 2026 | 558 | 6.760 |
Why?
| | Catheter Ablation | 16 | 2026 | 356 | 5.470 |
Why?
| | Pacemaker, Artificial | 6 | 2025 | 129 | 2.570 |
Why?
| | Atrial Appendage | 4 | 2026 | 36 | 2.440 |
Why?
| | Defibrillators, Implantable | 8 | 2025 | 381 | 2.060 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2023 | 154 | 1.980 |
Why?
| | Aortic Valve Stenosis | 5 | 2023 | 257 | 1.520 |
Why?
| | Stroke | 4 | 2024 | 1272 | 1.330 |
Why?
| | Cardiac Resynchronization Therapy | 3 | 2021 | 63 | 1.280 |
Why?
| | Anticoagulants | 6 | 2025 | 750 | 1.270 |
Why?
| | Ventricular Premature Complexes | 5 | 2025 | 37 | 1.270 |
Why?
| | Atrial Flutter | 3 | 2025 | 47 | 1.250 |
Why?
| | Arrhythmias, Cardiac | 4 | 2021 | 355 | 1.240 |
Why?
| | Percutaneous Coronary Intervention | 5 | 2017 | 559 | 1.240 |
Why?
| | Tachycardia, Ventricular | 7 | 2022 | 180 | 1.100 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2025 | 394 | 1.080 |
Why?
| | Transposition of Great Vessels | 2 | 2025 | 42 | 1.070 |
Why?
| | Coronary Stenosis | 2 | 2017 | 41 | 0.940 |
Why?
| | Tricuspid Valve | 2 | 2025 | 43 | 0.940 |
Why?
| | Arterial Switch Operation | 1 | 2025 | 16 | 0.910 |
Why?
| | Hospitals | 4 | 2019 | 732 | 0.880 |
Why?
| | Elective Surgical Procedures | 1 | 2026 | 202 | 0.830 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 2 | 2021 | 28 | 0.810 |
Why?
| | Risk Factors | 19 | 2026 | 10874 | 0.770 |
Why?
| | Heart Atria | 3 | 2024 | 143 | 0.770 |
Why?
| | Aortic Valve | 5 | 2023 | 364 | 0.760 |
Why?
| | Pericardial Effusion | 1 | 2022 | 22 | 0.750 |
Why?
| | Treatment Outcome | 16 | 2026 | 11831 | 0.710 |
Why?
| | Registries | 11 | 2026 | 2410 | 0.680 |
Why?
| | Electrophysiologic Techniques, Cardiac | 2 | 2019 | 82 | 0.660 |
Why?
| | Esophagus | 2 | 2023 | 262 | 0.650 |
Why?
| | Coronary Sinus | 1 | 2020 | 9 | 0.650 |
Why?
| | Therapeutic Irrigation | 2 | 2019 | 68 | 0.630 |
Why?
| | Patient Discharge | 2 | 2025 | 992 | 0.620 |
Why?
| | Postoperative Complications | 6 | 2026 | 2962 | 0.610 |
Why?
| | Cardiac Catheterization | 2 | 2022 | 570 | 0.610 |
Why?
| | Shock | 1 | 2020 | 109 | 0.600 |
Why?
| | Humans | 56 | 2026 | 145491 | 0.590 |
Why?
| | Coronary Artery Disease | 3 | 2014 | 760 | 0.580 |
Why?
| | Esophageal Fistula | 1 | 2019 | 21 | 0.580 |
Why?
| | Length of Stay | 1 | 2025 | 1348 | 0.580 |
Why?
| | Aged | 27 | 2026 | 26125 | 0.540 |
Why?
| | Heart Block | 1 | 2018 | 41 | 0.530 |
Why?
| | Cryosurgery | 1 | 2018 | 46 | 0.520 |
Why?
| | Administration, Oral | 3 | 2025 | 863 | 0.510 |
Why?
| | Male | 35 | 2026 | 72817 | 0.510 |
Why?
| | Tetralogy of Fallot | 1 | 2018 | 78 | 0.500 |
Why?
| | Electrocardiography | 6 | 2023 | 669 | 0.500 |
Why?
| | Patient Participation | 3 | 2026 | 437 | 0.500 |
Why?
| | Middle Aged | 24 | 2026 | 36176 | 0.500 |
Why?
| | Tilidine | 1 | 2016 | 2 | 0.480 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 132 | 0.480 |
Why?
| | Practice Patterns, Physicians' | 2 | 2017 | 1369 | 0.480 |
Why?
| | United States | 12 | 2026 | 16115 | 0.470 |
Why?
| | Pulmonary Valve | 1 | 2018 | 102 | 0.470 |
Why?
| | Oxycodone | 1 | 2016 | 54 | 0.460 |
Why?
| | Assisted Circulation | 1 | 2015 | 26 | 0.450 |
Why?
| | Coronary Artery Bypass | 1 | 2017 | 271 | 0.450 |
Why?
| | Retrospective Studies | 19 | 2026 | 17269 | 0.440 |
Why?
| | Time Factors | 10 | 2025 | 7171 | 0.440 |
Why?
| | Preoperative Care | 1 | 2018 | 380 | 0.440 |
Why?
| | Antihypertensive Agents | 2 | 2019 | 518 | 0.440 |
Why?
| | Naloxone | 1 | 2016 | 132 | 0.430 |
Why?
| | Female | 32 | 2026 | 78763 | 0.420 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 299 | 0.410 |
Why?
| | Plaque, Atherosclerotic | 1 | 2014 | 61 | 0.410 |
Why?
| | Blue Cross Blue Shield Insurance Plans | 1 | 2013 | 2 | 0.390 |
Why?
| | Prescriptions | 2 | 2023 | 75 | 0.390 |
Why?
| | Cardiomyopathies | 3 | 2025 | 335 | 0.390 |
Why?
| | Hospitals, Teaching | 1 | 2013 | 120 | 0.380 |
Why?
| | United States Department of Veterans Affairs | 1 | 2017 | 775 | 0.370 |
Why?
| | Thiophenes | 1 | 2013 | 121 | 0.370 |
Why?
| | Tachycardia, Supraventricular | 2 | 2022 | 49 | 0.350 |
Why?
| | Cardiac Surgical Procedures | 1 | 2018 | 613 | 0.340 |
Why?
| | Heart Failure | 4 | 2021 | 2329 | 0.330 |
Why?
| | Action Potentials | 3 | 2025 | 502 | 0.320 |
Why?
| | Piperazines | 1 | 2013 | 378 | 0.320 |
Why?
| | Healthcare Disparities | 1 | 2017 | 739 | 0.320 |
Why?
| | Hypertension | 2 | 2019 | 1273 | 0.320 |
Why?
| | Recurrence | 3 | 2026 | 1142 | 0.310 |
Why?
| | Atrioventricular Block | 2 | 2021 | 44 | 0.310 |
Why?
| | Heart Rate | 3 | 2025 | 859 | 0.310 |
Why?
| | Acute Coronary Syndrome | 1 | 2013 | 297 | 0.300 |
Why?
| | Risk Assessment | 6 | 2025 | 3759 | 0.300 |
Why?
| | Decision Support Techniques | 2 | 2026 | 473 | 0.290 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2013 | 505 | 0.290 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2772 | 0.280 |
Why?
| | Cost-Benefit Analysis | 2 | 2022 | 645 | 0.260 |
Why?
| | Bundle-Branch Block | 3 | 2023 | 37 | 0.260 |
Why?
| | Heart Conduction System | 2 | 2024 | 96 | 0.240 |
Why?
| | Cardiac Pacing, Artificial | 2 | 2023 | 84 | 0.240 |
Why?
| | Electric Countershock | 3 | 2023 | 127 | 0.220 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2185 | 0.220 |
Why?
| | Government Regulation | 1 | 2024 | 39 | 0.210 |
Why?
| | Heart Defects, Congenital | 2 | 2022 | 909 | 0.210 |
Why?
| | Thromboembolism | 1 | 2025 | 128 | 0.210 |
Why?
| | Clinical Decision-Making | 2 | 2024 | 368 | 0.210 |
Why?
| | Off-Label Use | 1 | 2023 | 51 | 0.200 |
Why?
| | Aged, 80 and over | 5 | 2026 | 8326 | 0.190 |
Why?
| | Death, Sudden, Cardiac | 2 | 2021 | 231 | 0.180 |
Why?
| | Guideline Adherence | 2 | 2019 | 590 | 0.180 |
Why?
| | Sweden | 1 | 2022 | 113 | 0.180 |
Why?
| | Pulmonary Veins | 1 | 2022 | 106 | 0.170 |
Why?
| | Rivaroxaban | 1 | 2023 | 269 | 0.170 |
Why?
| | Adult | 8 | 2025 | 40707 | 0.170 |
Why?
| | Prospective Studies | 5 | 2019 | 8039 | 0.170 |
Why?
| | Accessory Atrioventricular Bundle | 1 | 2020 | 13 | 0.160 |
Why?
| | Ventricular Fibrillation | 1 | 2020 | 64 | 0.160 |
Why?
| | Bradycardia | 1 | 2021 | 62 | 0.160 |
Why?
| | Swine | 1 | 2023 | 833 | 0.160 |
Why?
| | Cardiac Catheters | 1 | 2019 | 16 | 0.150 |
Why?
| | Death | 1 | 2020 | 131 | 0.150 |
Why?
| | Papillary Muscles | 1 | 2019 | 13 | 0.150 |
Why?
| | Follow-Up Studies | 5 | 2024 | 5426 | 0.150 |
Why?
| | Temperature | 1 | 2023 | 681 | 0.150 |
Why?
| | Coffee | 1 | 2019 | 15 | 0.150 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 24 | 0.150 |
Why?
| | Electrodes | 1 | 2019 | 112 | 0.150 |
Why?
| | Technology | 1 | 2020 | 95 | 0.150 |
Why?
| | Aortic Valve Insufficiency | 1 | 2019 | 43 | 0.150 |
Why?
| | Ventricular Function, Left | 2 | 2020 | 539 | 0.150 |
Why?
| | Diffusion of Innovation | 1 | 2019 | 97 | 0.150 |
Why?
| | Inpatients | 1 | 2023 | 550 | 0.140 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 63 | 0.140 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 68 | 0.140 |
Why?
| | Heart Valve Diseases | 1 | 2020 | 152 | 0.140 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1585 | 0.140 |
Why?
| | Heparin | 1 | 2020 | 245 | 0.140 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 155 | 0.140 |
Why?
| | Coronary Angiography | 2 | 2017 | 343 | 0.130 |
Why?
| | Equipment Design | 1 | 2019 | 532 | 0.130 |
Why?
| | Myocardial Infarction | 2 | 2016 | 1216 | 0.130 |
Why?
| | Echocardiography, Stress | 1 | 2017 | 29 | 0.130 |
Why?
| | Sarcoidosis | 1 | 2019 | 163 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2019 | 296 | 0.120 |
Why?
| | Anti-Arrhythmia Agents | 3 | 2023 | 144 | 0.120 |
Why?
| | Pharmacovigilance | 1 | 2016 | 24 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1507 | 0.120 |
Why?
| | Hot Temperature | 1 | 2019 | 411 | 0.120 |
Why?
| | World Health Organization | 1 | 2016 | 104 | 0.120 |
Why?
| | Intra-Aortic Balloon Pumping | 1 | 2015 | 20 | 0.110 |
Why?
| | Vasodilator Agents | 1 | 2017 | 330 | 0.110 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2129 | 0.110 |
Why?
| | Disease Management | 1 | 2019 | 654 | 0.110 |
Why?
| | Shock, Cardiogenic | 1 | 2015 | 68 | 0.110 |
Why?
| | Drug Combinations | 1 | 2016 | 397 | 0.110 |
Why?
| | Stroke Volume | 3 | 2025 | 654 | 0.100 |
Why?
| | Arterial Occlusive Diseases | 1 | 2014 | 95 | 0.100 |
Why?
| | Chagas Cardiomyopathy | 1 | 2014 | 27 | 0.100 |
Why?
| | Exercise | 1 | 2026 | 2192 | 0.100 |
Why?
| | Prasugrel Hydrochloride | 1 | 2013 | 22 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 754 | 0.100 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2013 | 24 | 0.100 |
Why?
| | Contraindications | 1 | 2013 | 91 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 945 | 0.100 |
Why?
| | Diabetic Angiopathies | 1 | 2015 | 263 | 0.100 |
Why?
| | Drug Utilization Review | 1 | 2013 | 62 | 0.090 |
Why?
| | Michigan | 1 | 2013 | 138 | 0.090 |
Why?
| | Blood Pressure | 1 | 2019 | 1782 | 0.090 |
Why?
| | Drug Utilization | 1 | 2013 | 167 | 0.090 |
Why?
| | Catheters | 2 | 2022 | 76 | 0.080 |
Why?
| | Societies, Medical | 1 | 2015 | 898 | 0.080 |
Why?
| | Hemorrhage | 1 | 2016 | 826 | 0.080 |
Why?
| | Medication Adherence | 1 | 2015 | 543 | 0.080 |
Why?
| | Comorbidity | 1 | 2015 | 1659 | 0.080 |
Why?
| | Quality Indicators, Health Care | 1 | 2013 | 336 | 0.080 |
Why?
| | Seizures | 1 | 2014 | 482 | 0.080 |
Why?
| | Incidence | 3 | 2021 | 2915 | 0.080 |
Why?
| | Echocardiography | 2 | 2025 | 648 | 0.070 |
Why?
| | Hospital Mortality | 1 | 2013 | 1044 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2015 | 2950 | 0.060 |
Why?
| | Young Adult | 2 | 2020 | 14192 | 0.050 |
Why?
| | Quality Improvement | 1 | 2013 | 1294 | 0.050 |
Why?
| | Bundle of His | 1 | 2023 | 19 | 0.050 |
Why?
| | Atrioventricular Node | 1 | 2021 | 15 | 0.040 |
Why?
| | Cardiac Electrophysiology | 1 | 2021 | 21 | 0.040 |
Why?
| | Tachycardia | 1 | 2021 | 57 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5891 | 0.040 |
Why?
| | Cohort Studies | 2 | 2026 | 5992 | 0.040 |
Why?
| | Animals | 1 | 2023 | 38141 | 0.040 |
Why?
| | Colorado | 2 | 2021 | 4572 | 0.040 |
Why?
| | Patient Readmission | 2 | 2016 | 769 | 0.040 |
Why?
| | Antithrombins | 1 | 2020 | 70 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 590 | 0.040 |
Why?
| | Systole | 1 | 2019 | 181 | 0.040 |
Why?
| | Mitral Valve | 1 | 2019 | 97 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 4323 | 0.030 |
Why?
| | Artificial Intelligence | 1 | 2023 | 383 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 287 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2021 | 909 | 0.030 |
Why?
| | Hospitalization | 2 | 2021 | 2458 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 1046 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1896 | 0.030 |
Why?
| | Research Design | 1 | 2021 | 1134 | 0.030 |
Why?
| | Reoperation | 1 | 2018 | 631 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 905 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2093 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1332 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2855 | 0.020 |
Why?
| | Child | 2 | 2022 | 22680 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2862 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3424 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 6070 | 0.020 |
Why?
| | Adolescent | 1 | 2022 | 22485 | 0.010 |
Why?
|
|
Sandhu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|